EGFR and inflammatory bowel disease: Pathway analysis of human clinical samples demonstrated that inflammation-associated pathways, particularly those involved in chemokine-linked signaling, were highly correlated with EGFR expression in the intestinal tissues of patients with IBD (Fig. 4a).